More importantly, our data showed that inhibiting LRRC1 expression in vivo can alleviate liver fibrosis in a CCl4-induced mouse model, implying that LRRC1 could serve as a promising target for treating liver fibrosis. This evidence concerns the gene LRRC1 and Hepatic fibrosis.